| 000 | 01745 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517064431.0 | ||
| 264 | 0 | _c20161107 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v21.i43.12439 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQiu, Bin | |
| 245 | 0 | 0 |
_aCombined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cNov 2015 |
||
| 300 |
_a12439-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xetiology |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aCholangiopancreatography, Magnetic Resonance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Portal _xetiology |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
| 650 | 0 | 4 |
_aLiver Neoplasms _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPortal Pressure |
| 650 | 0 | 4 |
_aPortasystemic Shunt, Transjugular Intrahepatic _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhao, Meng-Fei | |
| 700 | 1 | _aYue, Zhen-Dong | |
| 700 | 1 | _aZhao, Hong-Wei | |
| 700 | 1 | _aWang, Lei | |
| 700 | 1 | _aFan, Zhen-Hua | |
| 700 | 1 | _aHe, Fu-Liang | |
| 700 | 1 | _aDai, Shan | |
| 700 | 1 | _aYao, Jian-Nan | |
| 700 | 1 | _aLiu, Fu-Quan | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 21 _gno. 43 _gp. 12439-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v21.i43.12439 _zAvailable from publisher's website |
| 999 |
_c25483322 _d25483322 |
||